Crispin Blunt's Conservative Drug Policy Reform Group aimed to facilitate access to cannabis-based medical products and pursue significant drug policy reforms before folding amid controversy.
The CDPRG, led by Blunt, pushed for changing laws surrounding psilocybin, advocating for its reclassification to allow medical prescriptions, showcasing an attempt to reform drug regulations.
Collection
[
|
...
]